WAPNICK PAMELA (Chief Financial Officer) sold 2.9% of their position (1.81K shares) of METAGENOMI THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/7/2025ACC: 0000950170-25-035565
Officer· Chief Financial Officer
Since Mar 2026
-1.81K
Net shares
Net seller
$3.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.81K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.81K
Price / share
$1.87
Trade value
$3.39K
% of position
2.9%
3/5/2025
61.49K→59.68K
Total
Net shares
−1.81K
Net value
-$3.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2025 | S · Sale | −1.81K | $1.87 | $3.39K | 2.9% | 61.49K | 59.68K |
| Total | −1.81K | -$3.39K | ||||||
Derivative Transactions0
No derivative transactions reported